Published in Surgery Litigation and Law Weekly, November 24th, 2006
This trend article about University of Ulm, Germany, is an immediate alert from NewsRx to identify developing directions of research.
Study 1: C-11-choline PET/CT could distinguish prostate cancer (PCa) from areas with benign hyperplasia, chronic prostatitis, or normal prostate tissue.
"The ability of C-11-choline and multimodality fusion imaging with integrated PET and contrast-enhanced CT (PET/CT) was investigated to delineate PCa within the prostate and to differentiate cancer tissue from normal prostate, benign prostate hyperplasia, and focal...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Surgery Litigation and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.